Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
Based upon the preclinical evidence in models of diabetic nephropathy under conditions approximating both type I and II diabetes, treatment with alagebrium appears to have favorable and advantageous effects on the biochemical, structural, pathological and functional hallmarks of diabetic nephropathy. The renoprotective effects of alagebrium in preclinical models favor the evaluation of this drug in patients with type I diabetes.
Epistemonikos ID: 458f2cdf944f0258245dae9f1da7102a8d8e4e44
First added on: May 04, 2024